<span id="midArticle_start"/> India's Sun Pharma Advanced ResearchCompany Ltd (SPARC)
<span id="midArticle_0"/>* Licenses xelprostm (latanoprost bak-free) to SunPharmaceutical Industries Ltd
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>* SPARC to receive upfront payment of $3 million, certainother milestone payments, totaling to $16 million from SunPharma - statementFurther company coverage: (Mumbai newsroom)
<span id="midArticle_2"/> <span class="third-article-divide"/>
<span id="midArticle_0"/>* Licenses xelprostm (latanoprost bak-free) to SunPharmaceutical Industries Ltd
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>* SPARC to receive upfront payment of $3 million, certainother milestone payments, totaling to $16 million from SunPharma - statementFurther company coverage: (Mumbai newsroom)
<span id="midArticle_2"/> <span class="third-article-divide"/>
via Smart Health Shop Forum http://ift.tt/1JDeYVj
No comments:
Post a Comment